All
Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
Tubulis announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing.
BlueTech Inalve announces the closing of a €4.7 million financing round
The participation of the Blue Forward FundTM, managed by Seventure Partners, and the PSIM fund, managed by Bpifrance on behalf of the French government, confirms the strong...
Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development
The company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and Khosla Ventures, reflects enthusiasm for Siolta's...
Les Assises: Zurich Resilience Solutions announces the launch of “Quantification as a Service”, powered by Citalid
Julien Chamonal, Chief Revenue Officer at Citalid, and Vivien Bilquez, Principal Cyber Risk Engineer at Zurich Insurance, co-hosted a presentation titled Cyber Insurance:...
Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.
Maat Pharma announces that the DSMB unanimoulsy recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host Disease...
IDnow introduces fully automated identity proofing solution with CPF database checks to Brazilian gambling market
IDnow, a leading identity proofing platform provider, announces the integration of the Brazilian CPF database check (Cadastro de Pessoas Físicas, Register of Natural Persons)...